Kyle Gano, CEO: Neurocrine Biosciences NBIX Sell · Filed 25/02/12

Trade details

Type: Insider sale
Amount: $116,022.2
Shares · price: 980 sh · $118.39 a share
Held after: 137,658 sh
Stock: Neurocrine Biosciences NBIX
Person: Kyle GanoCEO
Trade date: 25/02/10
Filed: 25/02/12
Days to filing: 2 days

Sold 0.7% of holdings

Share of holding sold: 0.7%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 25/01/11~25/03/12

Kyle Gano's recent trades

Kyle GanoCEO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$4.6M
34,588 sh
$4.6M
Filed 01/20
Traded 01/16
Kyle GanoCEO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$240.5K
1,812 sh
$240.5K
Filed 01/20
Traded 01/16
Kyle GanoCEO
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$4.9M
36,400 sh
$4.9M
Filed 01/16
Traded 01/16
Kyle GanoCEO
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$42.6K
300 sh
$42.6K
Filed 25/11/05
Traded 25/11/04
Kyle GanoCEO
SellNeurocrine Biosciences
Sell
Neurocrine Biosciences
NBIX
$42.6K
300 sh
$42.6K
Filed 25/11/04
Traded 25/11/04

Kyle Gano, CEO — sold $116K of Neurocrine Biosciences NBIX · 0.7% of holdings · 10b5-1 plan | Whalegun